Your browser doesn't support javascript.
loading
New Conversion Formula Between B-Type Natriuretic Peptide and N-Terminal-Pro-B-Type Natriuretic Peptide - Analysis From a Multicenter Study.
Ishihara, Satomi; Hiramitsu, Shinya; Kanaoka, Koshiro; Taki, Mizuri; Nakagawa, Hitoshi; Ueda, Tomoya; Seno, Ayako; Nishida, Taku; Onoue, Kenji; Soeda, Tsunenari; Ohtani, Tomohito; Watanabe, Makoto; Kawakami, Rika; Sakata, Yasushi; Kario, Kazuomi; Saito, Yoshihiko.
Afiliação
  • Ishihara S; Department of Cardiovascular Medicine, Nara Medical University.
  • Hiramitsu S; Hiramitsu Heart Clinic.
  • Kanaoka K; Department of Cardiovascular Medicine, Nara Medical University.
  • Taki M; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine.
  • Nakagawa H; Department of Cardiovascular Medicine, Nara Medical University.
  • Ueda T; Department of Cardiovascular Medicine, Nara Medical University.
  • Seno A; Department of Cardiovascular Medicine, Nara Medical University.
  • Nishida T; Department of Cardiovascular Medicine, Nara Medical University.
  • Onoue K; Department of Cardiovascular Medicine, Nara Medical University.
  • Soeda T; Department of Cardiovascular Medicine, Nara Medical University.
  • Ohtani T; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine.
  • Watanabe M; Department of Cardiovascular Medicine, Nara Medical University.
  • Kawakami R; Department of Cardiovascular Medicine, Nara Medical University.
  • Sakata Y; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine.
  • Kario K; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine.
  • Saito Y; Department of Cardiovascular Medicine, Nara Medical University.
Circ J ; 86(12): 2010-2018, 2022 11 25.
Article em En | MEDLINE | ID: mdl-35613887
ABSTRACT

BACKGROUND:

Although B-type natriuretic peptide (BNP) and N-terminal (NT)-proBNP are commonly used markers of heart failure, a simple conversion formula between these peptides has not yet been developed for clinical use.Methods and 

Results:

A total of 9,394 samples were obtained from Nara Medical University, Jichi Medical University, and Osaka University. We randomly selected 70% for a derivation set to investigate a conversion formula from BNP to NT-proBNP using estimated glomerular filtration rate (eGFR) and body mass index (BMI); the remaining 30% was used as the internal validation set and we used a cohort study from Nara Medical University as an external validation set. Multivariate linear regression analysis revealed a new conversion formula log NT-proBNP = 1.21 + 1.03 × log BNP - 0.009 × BMI - 0.007 × eGFR (r2=0.900, P<0.0001). The correlation coefficients between the actual and converted values of log NT-proBNP in the internal and external validation sets were 0.942 (P<0.0001) and 0.891 (P<0.0001), respectively. We applied this formula to samples obtained from patients administered with sacubitril/valsartan. After treatment initiation, NT-proBNP levels decreased and actual BNP levels increased. However, the calculated BNP levels decreased roughly parallel to the NT-proBNP levels.

CONCLUSIONS:

This new and simple conversion formula of BNP and NT-proBNP with eGFR and BMI is potentially useful in clinical practice.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeo Natriurético Encefálico / Insuficiência Cardíaca Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeo Natriurético Encefálico / Insuficiência Cardíaca Idioma: En Ano de publicação: 2022 Tipo de documento: Article